Beijing Bohui Innovation Biotechnology Co Ltd - ESG Rating & Company Profile powered by AI
The dashboard contains a questions and answers section on Beijing Bohui Innovation Biotechnology Co Ltd. The analysis of Beijing Bohui Innovation Biotechnology Co Ltd incorporates intelligence from across the web as well as from public disclosures by Beijing Bohui Innovation Biotechnology Co Ltd. Alternative corporations in the scoring peer group for Beijing Bohui Innovation Biotechnology Co Ltd are displayed.
Beijing Bohui Innovation Biotechnology Co Ltd in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
... | ... | ... | |
378 | Guangzhou Wondfo Biotech Co Ltd | 0.4 | Low |
379 | C R Bard Inc | 0.3 | Low |
380 | Beijing Bohui Innovation Biotechnology Co Ltd | 0.0 | Low |
380 | CU Medical Systems Inc | 0.0 | Low |
380 | Calypte Biomedical Corp | 0.0 | Low |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Beijing Bohui Innovation Biotechnology Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose current and historical energy intensity?
Does Beijing Bohui Innovation Biotechnology Co Ltd report the average age of the workforce?
Does Beijing Bohui Innovation Biotechnology Co Ltd reference operational or capital allocation in relation to climate change?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose its ethnicity pay gap?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose cybersecurity risks?
Does Beijing Bohui Innovation Biotechnology Co Ltd offer flexible work?
Does Beijing Bohui Innovation Biotechnology Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose the number of employees in R&D functions?
Does Beijing Bohui Innovation Biotechnology Co Ltd conduct supply chain audits?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Beijing Bohui Innovation Biotechnology Co Ltd conduct 360 degree staff reviews?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose the individual responsible for D&I?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose current and / or historical scope 2 emissions?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose water use targets?
Does Beijing Bohui Innovation Biotechnology Co Ltd have careers partnerships with academic institutions?
Did Beijing Bohui Innovation Biotechnology Co Ltd have a product recall in the last two years?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose incidents of discrimination?
Does Beijing Bohui Innovation Biotechnology Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Beijing Bohui Innovation Biotechnology Co Ltd issued a profit warning in the past 24 months?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose parental leave metrics?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose climate scenario or pathway analysis?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose the pay ratio of women to men?
Does Beijing Bohui Innovation Biotechnology Co Ltd support suppliers with sustainability related research and development?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Beijing Bohui Innovation Biotechnology Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Beijing Bohui Innovation Biotechnology Co Ltd involved in embryonic stem cell research?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose GHG and Air Emissions intensity?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose its waste policy?
Does Beijing Bohui Innovation Biotechnology Co Ltd report according to TCFD requirements?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose energy use targets?
Does Beijing Bohui Innovation Biotechnology Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Beijing Bohui Innovation Biotechnology Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Beijing Bohui Innovation Biotechnology Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence spectrometer and photometer, mass spectrometers, chip ion sources, microfluidic flow chemical analysis systems, life sciences related consumables, and ICP spectroscopy. The company was formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd. and changed its name to Beijing Bohui Innovation Biotechnology Group Co., Ltd. in August 2021. Beijing Bohui Innovation Biotechnology Group Co., Ltd. was founded in 2001 and is headquartered in Beijing, China.